BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21884695)

  • 21. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
    Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
    J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J; Qin Y; Li B; Sun Z; Yang B
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma.
    Nishida N; Kudo M; Nagasaka T; Ikai I; Goel A
    Hepatology; 2012 Sep; 56(3):994-1003. PubMed ID: 22407776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.
    Göbel G; Auer D; Gaugg I; Schneitter A; Lesche R; Müller-Holzner E; Marth C; Daxenbichler G
    Breast Cancer Res Treat; 2011 Nov; 130(1):109-17. PubMed ID: 21221769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling.
    Lehmann U; Berg-Ribbe I; Wingen LU; Brakensiek K; Becker T; Klempnauer J; Schlegelberger B; Kreipe H; Flemming P
    Clin Cancer Res; 2005 May; 11(10):3654-60. PubMed ID: 15897561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
    Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
    Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
    Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
    Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.
    Moribe T; Iizuka N; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Cancer; 2009 Jul; 125(2):388-97. PubMed ID: 19384946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M
    Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis.
    Huang W; Li T; Yang W; Chai X; Chen K; Wei L; Duan S; Li B; Qin Y
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):295-302. PubMed ID: 25923138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
    Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
    Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
    Fujita N; Nakayama T; Yamamoto N; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Morimoto K; Tamaki Y; Noguchi S
    Oncology; 2012; 83(5):273-82. PubMed ID: 22964822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
    Pasha HF; Mohamed RH; Radwan MI
    Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.